Clinical Trial

CNCMT：a Multi-center, Prospective, Single-arm Study

Study acronym: CNCMT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the safety and efficacy of Cadonilimab in neoadjuvant chemotherapy and maintenance therapy for high-risk advanced cervical cancer receiving concurrent chemoradiotherapy
Trial Details
NCT Number NCT06714084
Lead Sponsor Hubei Cancer Hospital
Collaborators: Yichang Central People's Hospital, Akeso Pharmaceuticals, Inc.
Conditions Locally Advanced Cervical Cancer, PD1, CTLA4
Enrollment 20 participants
Start Date 2024-10-08
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-03